Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Markus Eckstein, Veronika Bahlinger et al.|European Urology Open Science|2025Cited by 7
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Sven Wach, Markus Eckstein et al.|International Journal of Molecular Sciences|2024Cited by 4
Evaluation of FGFR Alteration Status in Urothelial TumorsVeronika Bahlinger, Robert Stöhr, Markus Eckstein et al.|Methods in molecular biology|2023Cited by 2
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancerFabienne Lange, Markus Eckstein, Carol I. Geppert et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2024Cited by 1
Genomic characterization of upper urinary tract urothelial carcinoma and clonal evolution of intravesical recurrencesJ. Alberto Nakauma-González, J. Boormans, Veronika Bahlinger et al.|medRxiv|2026Cited by 0